Arch Point Investors Catabasis Pharmaceuticals, Inc. Transaction History
Arch Point Investors
- $280 Million
- Q1 2025
About Catabasis Pharmaceuticals, Inc.
- Ticker CATB
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,948,800
- Market Cap $657M